Company profile: Nuubo
1.1 - Company Overview
Company description
- Provider of wireless, wearable technologies for physiological monitoring via the nECG DYNAMIC PLATFORM to perform and read electrocardiograms remotely. Offerings include the Nuubo Textile Electrode for high-quality ECG during daily activities, a 30-day Nuubo Monitoring Report, Nuubo Device Installation guidance, the myNuubo app for symptom tracking and charge reminders, and scientific research in validation, risk stratification, arrhythmias, and cardiac rehabilitation.
Products and services
- MyNuubo App: App-based tool that guides patients using the Nuubo product, records symptom events, and issues device charging reminders to support continuous monitoring adherence and usability
- Nuubo Monitoring Report: 30-day report compiling patient data, documented symptoms, categorized arrhythmias, and ECG trends, delivering structured remote findings to aid clinical interpretation and longitudinal rhythm assessment
- Nuubo Textile Electrode: Wearable textile electrode that captures high-quality ECG signals during daily activities, maximizing comfort while enabling continuous cardiac data acquisition for remote physiological monitoring
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nuubo
Mindframe
HQ: United States
Website
- Description: Provider of solutions for treating ischemic stroke, offering the MindFrame Capture LP device that delivers rapid flow restoration and clot extraction to help clinicians provide improved clinical outcomes, as well as MINDFRAME CAPTURE for ICA-T and basilar arteries, and MCA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mindframe company profile →
BTG
HQ: United Kingdom
Website
- Description: Provider of interventional medicine, pharmaceuticals, and licensing solutions, acquiring, developing, manufacturing, and commercializing products globally. Interventional oncology offerings include beads and TheraSphere Y-90 Glass Microspheres for HCC; other devices include Jetstream Atherectomy System, Vercise Genus DBS, Varithena 1% foam, WaveWriter Alpha SCS, and AcuPulse DUO CO2 Laser.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BTG company profile →
Action Pharma
HQ: Denmark
Website
- Description: Provider of R&D-focused drug discovery and development, creating pharmaceutical products and treatment concepts for cardiovascular and inflammatory diseases and acquired metabolic diseases, including type-II diabetes and obesity; product pipeline includes AP214.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Action Pharma company profile →
Tangent Medical
HQ: United States
Website
- Description: Provider of intravenous catheters and associated products to improve infusion therapy for patients and healthcare workers, based on proprietary technology exclusively licensed from the University of Michigan's Medical Innovation Center; development-stage medical device company founded in Ann Arbor in 2009.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tangent Medical company profile →
VisCardia
HQ: United States
Website
- Description: Provider of proprietary implantable medical therapy for heart failure using Synchronized Diaphragmatic Stimulation to modulate intrathoracic pressures and augment cardiac hemodynamics. Products include the VisONE Therapy, an Implantable Pulse Generator, sensing and therapy lead electrodes, an external programmer with telemetry wand, and a laparoscopic implant tool for minimally invasive placement.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full VisCardia company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nuubo
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nuubo
2.2 - Growth funds investing in similar companies to Nuubo
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nuubo
4.2 - Public trading comparable groups for Nuubo
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →